Buprenorphine Treatment of Fentanyl-Related Opioid Use Disorder

Prim Care Companion CNS Disord. 2022 Apr 26;24(3):21cr03163. doi: 10.4088/PCC.21cr03163.

Authors

Oluwole Jegede^{1

2

3}, Suprit Parida^{1

4}, Joao P De Aquino^{1

2

4}

Affiliations

¹ Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
² Connecticut Mental Health Center, New Haven, Connecticut.
³ Corresponding author: Oluwole Jegede, MD, MPH, Yale University School of Medicine, 34 Park St, New Haven, CT 06519 (oluwole.jegede@yale.edu).
⁴ VA Connecticut Healthcare System, West Haven, Connecticut.

PMID: 35486939
DOI: 10.4088/PCC.21cr03163

No abstract available

MeSH terms

Buprenorphine* / therapeutic use
Fentanyl / adverse effects
Humans
Opiate Substitution Treatment
Opioid-Related Disorders* / drug therapy

Substances

Buprenorphine
Fentanyl